Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 2021; Volume 99,Issue 1

Minireview

  • You have access
    Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity
    Safaa H Hammoud, Zena Wehbe, Samar Abdelhady, Firas Kobeissy, Ali H. Eid and Ahmed F. El-Yazbi
    Molecular Pharmacology January 2021, 99 (1) 17-28; DOI: https://doi.org/10.1124/molpharm.120.000119
  • You have access
    Targeting Angiotensin-Converting Enzyme-2/Angiotensin-(1-7)/Mas Receptor Axis in the Vascular Progenitor Cells for Cardiovascular Diseases
    Yagna P.R. Jarajapu
    Molecular Pharmacology January 2021, 99 (1) 29-38; DOI: https://doi.org/10.1124/mol.119.117580

Articles

  • You have access
    Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells
    Kanchan Vishnoi, Rong Ke, Karan S. Saini, Navin Viswakarma, Rakesh Sathish Nair, Subhasis Das, Zhengjia Chen, Ajay Rana and Basabi Rana
    Molecular Pharmacology January 2021, 99 (1) 1-16; DOI: https://doi.org/10.1124/molpharm.120.000029
  • A Benzodiazepine Ligand with Improved GABA<sub>A</sub> Receptor <em>α</em>5-Subunit Selectivity Driven by Interactions with Loop C
    Open Access
    A Benzodiazepine Ligand with Improved GABAA Receptor α5-Subunit Selectivity Driven by Interactions with Loop C
    Xenia Simeone, Filip Koniuszewski, Markus Müllegger, Andreas Smetka, Friederike Steudle, Roshan Puthenkalam, Margot Ernst and Petra Scholze
    Molecular Pharmacology January 2021, 99 (1) 39-48; DOI: https://doi.org/10.1124/molpharm.120.000067
  • Open Access
    Characterization of Vixotrigine, a Broad-Spectrum Voltage-Gated Sodium Channel Blocker
    Christopher A Hinckley, Yuri Kuryshev, Alissende Sers, Alexander Barre, Bruno Buisson, Himanshu Naik and Mihaly Hajos
    Molecular Pharmacology January 2021, 99 (1) 49-59; DOI: https://doi.org/10.1124/molpharm.120.000079
  • You have access
    Protective Effects of Flavonoids in Acute Models of Light-Induced Retinal Degeneration
    Joseph T. Ortega, Tanu Parmar, Marcin Golczak and Beata Jastrzebska
    Molecular Pharmacology January 2021, 99 (1) 60-77; DOI: https://doi.org/10.1124/molpharm.120.000072
  • Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the <em>α</em><sub>2</sub><em>β</em><sub>3</sub><em>γ</em><sub>2</sub> GABA<sub>A</sub> Receptor
    Open Access
    Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the α2β3γ2 GABAA Receptor
    Brandon Pressly, Ruth D. Lee, Bogdan Barnych, Bruce D. Hammock and Heike Wulff
    Molecular Pharmacology January 2021, 99 (1) 78-91; DOI: https://doi.org/10.1124/molpharm.120.000090
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 99 (1)
Molecular Pharmacology
Vol. 99, Issue 1
1 Jan 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics